10.24.05: C. E. Unterberg, Towbin Specialty Pharmaceutical Conference
4 analysts and top management from 19 firms examine the Specialty Pharmaceutical sector in this 81 page conference issue from The Wall Street Transcript.

  1. Emerging Growth Life Sciences Companies: Keay Nakae, C. E. Unterberg, Towbin

  2. Pulmonary Arterial Hypertension: Andrew Fein, C. E. Unterberg, Towbin

  3. Oncology Companies: Katherine Kim, C. E. Unterberg, Towbin

  4. Specialty Pharma Emerging Growth Companies: Angela Larson, C. E. Unterberg, Towbin

  5. CEO Interviews (average 2,500 words): Top management from 19 sector firms examine the outlook for their firm and sector. Firms interviewed include: Auxilium Pharmaceuticals, Barrier Therapeutics, BioSphere Medical, CollaGenex Pharmaceuticals, Corcept Therapeutics Incorporated, Depomed, DOBI Medical International, Emisphere Technologies, Hana Biosciences, ISTA Pharmaceuticals, MannKind Corporation, Monogram Biosciences, Nanogen, NMT Medical, Penwest Pharmaceuticals, PhotoMedex, POZEN, Strategic Diagnostics and SuperGen.

    Topics covered: Oncology space  - Accelerating FDA approval  - Product failure risk  - Life sciences growth companies  - Equity market environment  - R&D funding  - Targeted pharmaceuticals  - Cardiac rhythm management  - Spinal cord stimulation  - Pulmonary arterial hypertension space 

    Companies covered: Abgenix (ABGX), Amgen (AMGN), ImClone Systems (IMCL), MGI PHARMA (MOGN), Celegene's (CELG), Genentech (DNA), Biogen Idec (BIIB), Thoratec (THOR), Laserscope (LSCP), Syneron (ELOS), Guidant (GDT), Medtronic (MDT), St. Jude (STJ), Advanced Neuromodulation (ANSI), Cyberonics (CYBX), J&J (JNJ), Shamir (SHMR), DOBI Medical (DBMI), Laserscope (LSCP), Regeneration Technologies (RTIX), Urologix (ULGX), CoTherix (CTRX), United Therapeutics (UTHR), Myogen (MYOG), Encysive Pharmaceuticals (ENCY) and Pfizer (PFE).
    ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us

    For immediate access online - click here to gain a password.  

    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
           		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

 

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.


Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE